A team of researchers from Penn State College of Medicine found a new target for treating diseases associated with human T-cell leukemia virus type 1 (HTLV-1).
SEC notches win in biopharma ‘shadow’ insider trading case
The SEC won its case against a former Medivation executive who bought stocks in a competing pharma company after learning the confidential news that Medivation